Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Sonoscape Medical
ISIN CNE100002P91
|WKN A2JJ7C
Market cap (in EUR)
1,533 m
Country
China
Sector
Healthcare
Dividend yield
0.35%
Overview
Description
Sonoscape Medical Corp. engages in the research and development, production and sales of medical diagnostic equipment. It also provides software development of medical devices biotechnology development, technology transfer, technical services, technical consultation, technical maintenance services for self-produced products and after-sales service for self-produced products. The company was founded by Jin Zhong Yao, Zhi Qiang Chen, and Kung Xiang Wu on September 27, 2002 and is headquartered in Shenzhen, China.
Healthcare Healthcare Equipment Other Medical Devices China
Financials
Key metrics
| Market capitalisation, EUR | 1,533 m |
| EPS, EUR | 0.02 |
| P/B ratio | 4.0 |
| P/E ratio | 185.3 |
| Dividend yield | 0.35% |
Income statement (2024)
| Revenue, EUR | 257 m |
| Net income, EUR | 18 m |
| Profit margin | 7.13% |
What ETF is Sonoscape Medical in?
There is 1 ETF which contains Sonoscape Medical.
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| Vanguard ESG Emerging Markets All Cap UCITS ETF (USD) Distributing | 0.00% | Equity Emerging Markets Social/Environmental | 15 |
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.